JP2004501939A5 - - Google Patents

Download PDF

Info

Publication number
JP2004501939A5
JP2004501939A5 JP2002506679A JP2002506679A JP2004501939A5 JP 2004501939 A5 JP2004501939 A5 JP 2004501939A5 JP 2002506679 A JP2002506679 A JP 2002506679A JP 2002506679 A JP2002506679 A JP 2002506679A JP 2004501939 A5 JP2004501939 A5 JP 2004501939A5
Authority
JP
Japan
Prior art keywords
ivermectin
present
use according
pharmaceutically acceptable
acceptable carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002506679A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004501939A (ja
JP3802485B2 (ja
Filing date
Publication date
Priority claimed from US09/605,747 external-priority patent/US6319945B1/en
Application filed filed Critical
Publication of JP2004501939A publication Critical patent/JP2004501939A/ja
Publication of JP2004501939A5 publication Critical patent/JP2004501939A5/ja
Application granted granted Critical
Publication of JP3802485B2 publication Critical patent/JP3802485B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002506679A 2000-06-29 2001-06-27 脂漏性皮膚炎の処置方法 Expired - Fee Related JP3802485B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/605,747 US6319945B1 (en) 2000-06-29 2000-06-29 Method of treatment of seborrheic dermatitis
PCT/US2001/041159 WO2002002056A2 (en) 2000-06-29 2001-06-27 Method of treatment of seborrheic dermatitis

Publications (3)

Publication Number Publication Date
JP2004501939A JP2004501939A (ja) 2004-01-22
JP2004501939A5 true JP2004501939A5 (enExample) 2006-03-30
JP3802485B2 JP3802485B2 (ja) 2006-07-26

Family

ID=24425042

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002506679A Expired - Fee Related JP3802485B2 (ja) 2000-06-29 2001-06-27 脂漏性皮膚炎の処置方法

Country Status (10)

Country Link
US (2) US6319945B1 (enExample)
EP (1) EP1294375B1 (enExample)
JP (1) JP3802485B2 (enExample)
CN (1) CN1171588C (enExample)
AT (1) ATE314068T1 (enExample)
AU (1) AU2002216748A1 (enExample)
CA (1) CA2384448C (enExample)
DE (1) DE60116302T2 (enExample)
ES (1) ES2252312T3 (enExample)
WO (1) WO2002002056A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897559B2 (en) * 2000-06-29 2011-03-01 Parks L Dean Dermatological composition and kit containing avermectin compound for treating dermatological conditions
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
AU2003247735B2 (en) 2002-06-26 2010-03-11 Avery Dennison Corporation Oriented films comprising polypropylene / olefin elastomer blends
BRPI0410503B8 (pt) * 2003-04-24 2021-05-25 Galderma Sa composição tópica e uso da composição
FR2854074B1 (fr) * 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
FR2894823B1 (fr) * 2005-12-20 2008-02-29 Galderma Sa Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie
CN103121320B (zh) 2006-06-14 2015-06-24 艾利丹尼森公司 可顺应和可冲切的轴向定向的标签原料和标签及制备方法
BRPI0713492A2 (pt) 2006-06-20 2012-01-24 Avery Dennison Corp filme polimérico de multi-camadas para rotulagem de adesivos de derretimento a quente e etiqueta e rótulo dos mesmos
CA2666365C (en) * 2006-10-12 2016-08-09 Topaz Pharmaceuticals Llc Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
US8901163B2 (en) 2007-01-03 2014-12-02 Galderma S.A. Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
WO2012054331A1 (en) 2010-10-20 2012-04-26 Galderma S.A. Method of treating otitis externa using macrocyclic lactone compound
EP2629772B1 (en) 2010-10-20 2016-05-18 Galderma S.A. Ivermectin for use in the treatment of hemorrhoids
US9782425B2 (en) 2013-07-08 2017-10-10 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US9233118B2 (en) 2013-07-08 2016-01-12 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
AU2015270854B2 (en) 2014-06-02 2018-08-02 Avery Dennison Corporation Films with enhanced scuff resistance, clarity, and conformability
CN110604741A (zh) * 2018-06-15 2019-12-24 瑞恩生化科技有限公司 抑制皮肤细胞增生的组合物及其应用
EP4062907A1 (fr) 2021-03-23 2022-09-28 Substipharm Formulation par voie orale d'ivermectine et utilisations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439924A (en) * 1991-12-23 1995-08-08 Virbac, Inc. Systemic control of parasites
US5877295A (en) * 1992-09-30 1999-03-02 The Center For Blood Research Antibodies which bind a subpopulation of Mac-1 (CD11b/CD18) molecules which mediate neutrophil adhesion to ICAM-1 and fibrinogen
DE4328689A1 (de) * 1993-08-26 1995-03-02 Beiersdorf Ag Verfahren zur Detektion und Zählung von Mikroorganismen
US5786344A (en) * 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5654312A (en) * 1995-06-07 1997-08-05 Andrulis Pharmaceuticals Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
WO1997044034A1 (en) * 1996-05-20 1997-11-27 Otsuka Pharmaceutical Co., Ltd. Remedy for rosacea
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
KR100315465B1 (ko) * 1998-11-23 2002-02-19 성재갑 수용성고분자와알코올을포함하는주사제용동물구충제조성물

Similar Documents

Publication Publication Date Title
JP2004501939A5 (enExample)
AR025071A1 (es) Aditivo para mejorar la resistencia al agua de formulaciones cosmeticas o dermatologicas
WO2002042462A3 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
WO2001043775A3 (en) Hydroxide-releasing agents as skin permeation enhancers
IL154693A (en) Use of testosterone gel to make a remedy for testosterone deficiency in women
BR0204596A (pt) Composição tópica, e, métodos para melhorar a aparência estética da pele, para intensificar a eficácia terapêutica de uma composição tópica para a pele, unha, lábios e/ou cabelo e para intensificar a produção de um constituinte de célula de planta predeterminada
AR015744A1 (es) Uso de dexmedetomidina para sedacion en terapia intensiva
US6855342B2 (en) Compositions and methods for high sorption of skin materials and delivery of sulfur
CA2384448A1 (en) Method of treatment of seborrheic dermatitis
MXPA01009951A (es) Composicion para aumentar permeacion de agentes topicos de la piel.
JP2002537232A5 (enExample)
JP2003503453A5 (ja) ガバペンチンおよびプレガバリンを含む相乗作用組成物
NZ516765A (en) Topical formulations comprising skin penetration agents and the use thereof
JP2003523397A5 (enExample)
CO5180574A1 (es) Micofenolato mofetil en asociacion con peg-inf-a
CA2474703A1 (en) Therapeutic agent of glaucoma comprising bunazosin and prostaglandins
JP2002501021A5 (enExample)
CA2286408A1 (en) The use of msm
JP2004262775A5 (enExample)
HK1039275A1 (zh) 含有二甲聚硅氧烷的阿昔洛韋組合物
WO2000013649A3 (fr) Utilisation du gluconate de lithium dans la fabrication d'un medicament pour le traitement de l'herpes et de la dermite seborrheique
SE9700617D0 (sv) New composition
JP2003502270A5 (enExample)
AU2001235527A1 (en) Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of the skin
ATE77238T1 (de) Primycin-loesungen.